Related Experiment Video
Updated: Sep 14, 2025

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
Generative artificial intelligence in diabetes healthcare.
Josep Vehi1,2, Omer Mujahid1, Aleix Beneyto1
1Modeling and Intelligent Control Engineering Laboratory, Institut d'Informàtica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.
Generative artificial intelligence (AI) offers powerful tools for diabetes care, generating synthetic data and simulating patient dynamics. Challenges like data needs and interpretability remain key areas for future research and ethical consideration.
Area of Science:
- Artificial Intelligence
- Biomedical Informatics
- Diabetes Technology
Background:
- Generative artificial intelligence (AI) models, particularly large language models, have advanced rapidly, impacting various fields.
- Generative AI excels at modeling, simulating, and generating high-fidelity data, addressing challenges like data scarcity and patient variability.
- Applications in diabetes care are emerging, promising personalized solutions and improved patient outcomes.
Purpose of the Study:
- To explore the application of deep generative models in diabetes healthcare.
- To review key generative AI models and their use in different data types relevant to diabetes.
- To outline the opportunities, limitations, and ethical considerations of generative AI in this domain.
Main Methods:
- Review of current literature on deep generative models.
- Exploration of models including variational autoencoders, generative adversarial networks, transformers, and diffusion models.
- Application analysis across tabular, time series, image, and text data in diabetes care.
Main Results:
- Generative AI models facilitate synthetic patient data generation and dataset augmentation.
- These models enable simulation of glucose-insulin dynamics and development of virtual coaches and digital twins.
- Key models discussed include VAEs, GANs, transformers, and diffusion models for diverse data types.
Conclusions:
- Generative AI presents significant opportunities for advancing diabetes care through data synthesis and simulation.
- Challenges such as model instability, data requirements, and interpretability need to be addressed.
- Ethical considerations are paramount for the responsible implementation of generative AI in diabetes healthcare.
More Related Videos
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Non-equilibrium in the Cell
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

